l-asparaginase: an effective agent in the treatment of acute lymphoblastic leukemia

Escalating intravenous methotrexate improves event-free survival in children with standard-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group

(2011) Y. Matloub et al.   BLOOD

Effectiveness of high-dose methotrexate in T-cell lymphoblastic leukemia and advanced-stage lymphoblastic lymphoma: a randomized study by the Children's Oncology Group (POG 9404)

(2011) B. L. Asselin et al.   BLOOD

Modern Therapy of Acute Lymphoblastic Leukemia

(2011) Renato Bassan et al.   JOURNAL OF CLINICAL ONCOLOGY

L-asparaginase treatment in acute lymphoblastic leukemia

(2010) Rob Pieters et al.   CANCER

Treatment of adults with BCR-ABL negative acute lymphoblastic leukaemia with a modified paediatric regimen

(2009) John M. Storring et al.   BRITISH JOURNAL OF HAEMATOLOGY

Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000

(2009) A Möricke et al.   LEUKEMIA

Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95

(2008) A. Moricke et al.   BLOOD

Current management and challenges of malignant disease in the CNS in paediatric leukaemia

(2008) Ching-Hon Pui et al.   LANCET ONCOLOGY

Biology and Treatment of Acute Lymphoblastic Leukemia

(2008) Rob Pieters et al.   PEDIATRIC CLINICS OF NORTH AMERICA